Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122497) titled 'Heterogeneity of Cancer-Associated Fibroblasts in Bladder Cancer Tumor Microenvironment and Its Prognostic Correlation Mechanism' on April 14.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The Fifth Affiliated Hospital of Zhengzhou University
Condition:
Bladder cancer
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-05-01
Target Sample Size: bladder cancer:80;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=317978
Disclaimer: Curated by HT Syndication....